Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
40m
Pfizer is said to have dropped RSV candidate from pipeline
Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...
ENDPOINTS NEWS
49m
GSK's RSV vaccine Arexvy shows long-term protection in Phase 3 trial
GSK said a dose of its RSV vaccine protected against illness over three years, according to new data presented at the CHEST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Human life expectancy study
To campaign for Harris
More troops to Ukraine?
Florida orders evacuations
Jets fire head coach Saleh
Richest female musician
Kemp suspends GA mayor
Sex abuse case dismissed
Ordered to open app store
Targeted by a cyberattack
Hears ghost gun rule case
Hamas backers sanctioned
Israel expands offensive
Rwandan virus screening
Hera mission launched
To replace lead water pipes
Tickets to climb to $5
Intel defensive briefings rise
North Dakota wildfires
US overdose deaths drop
Liquidation plan approved
Settles latest civil lawsuit
Medical copter crash kills 3
Win Nobel Prize in physics
SCOTUS denies appeal
Athlete payments approval
Harris on '60 Minutes'
States sue TikTok
Former aide charged
Related topics
United States
GSK
GlaxoSmithKline
Feedback